Biovie Total Liab from 2010 to 2024

BIVI Stock  USD 3.05  0.06  1.93%   
Biovie's Total Liabilities is increasing with slightly volatile movements from year to year. Total Liabilities is predicted to flatten to about 6.9 M. Total Liabilities is the total amount of all liabilities that Biovie Inc has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2013-09-30
Previous Quarter
9.7 M
Current Value
7.2 M
Quarterly Volatility
7.6 M
 
Yuan Drop
 
Covid
Check Biovie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biovie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 193.4 K, Interest Expense of 1.4 M or Selling General Administrative of 13.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.23 or PTB Ratio of 1.15. Biovie financial statements analysis is a perfect complement when working with Biovie Valuation or Volatility modules.
  
Check out the analysis of Biovie Correlation against competitors.

Latest Biovie's Total Liab Growth Pattern

Below is the plot of the Total Liab of Biovie Inc over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Biovie's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biovie's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Biovie Total Liab Regression Statistics

Arithmetic Mean5,497,242
Geometric Mean845,215
Coefficient Of Variation146.95
Mean Deviation6,523,742
Median996,374
Standard Deviation8,078,151
Sample Variance65.3T
Range23.6M
R-Value0.63
Mean Square Error42.6T
R-Squared0.39
Significance0.01
Slope1,132,706
Total Sum of Squares913.6T

Biovie Total Liab History

20246.9 M
20239.7 M
202219.8 M
202116.4 M
2020996.4 K
201923.6 M
2018443.5 K

About Biovie Financial Statements

Investors use fundamental indicators, such as Biovie's Total Liab, to determine how well the company is positioned to perform in the future. Although Biovie's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Liabilities9.7 M6.9 M

Currently Active Assets on Macroaxis

When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:
Check out the analysis of Biovie Correlation against competitors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.08)
Return On Assets
(0.67)
Return On Equity
(2.08)
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.